Articles By Jof Enriquez

  1. Australian Company BVT Raises $18 Million For Bionic Eye Clinical Trial

    Melbourne-based Bionic Vision Technologies (BVT) has raised US $18 million from Hong Kong-based investors China Huarong International Holdings and State Path Capital Limited to proceed with clinical studies testing the company's bionic eye for patients with retinitis pigmentosa, a degenerative condition that is the most common cause of inherited blindness.

  2. Philips, B. Braun Partner On Ultrasound-Guided Regional Anesthesia, Vascular Access Procedures

    Philips and B. Braun are launching a co-branded ultrasound system on which to base upcoming jointly-developed, image-guided therapy innovations in regional anesthesia and vascular access procedures.

  3. Samsung, MedyMatch Collaborate On AI-Directed Acute Stroke Detection

    Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics, is integrating its computed tomography (CT) and other imaging equipment with artificial intelligence (A.I.) clinical decision support technology developed by Israeli startup MedyMatch.

  4. Siemens Opts Not To Divest Healthineers

    Siemens CEO Jose Kaeser says the company intends to maintain a majority stake in its healthcare business, Healthineers, after a potential spin-off or initial public offering (IPO).

  5. FDA's Program Alignment To Make Inspections More Efficient

    The U.S. Food and Drug Administration's Office of Regulatory Affairs (ORA) will start implementing on May 15 its program alignment, which will shift FDA personnel from geography-based to commodity-based teams and make inspections more efficient.

  6. FDA, Industry Say MDUFA Renewal A Big Win For Patients, Medtech Innovation

    In the latest Congressional hearing to tackle 2017 User Fee Act (UFA) reauthorizations, FDA's Center for Devices and Radiological Health (CDRH) Director Jeffrey Shuren and representatives from industry groups pressed members of the House Energy & Commerce Committee’s (E&C) Subcommittee on Health to renew the Medical Device User Fee Amendments (MDUFA), which expires in September 2017 and must be reauthorized for the Fiscal Years 2018 to 2022.

  7. CDRH Invites Participants For Experiential Learning Program

    The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) is inviting participants from medical device companies, academia, clinical facilities, research organizations, medical device incubators, and other stakeholders to participate in the center's Experiential Learning Program (ELP), a collaborative effort with industry to facilitate the premarket review process.

  8. BYU Researchers Develop Flexible Glass For Microfluidic Nanodevices

    Researchers at Brigham Young University (BYU) have developed a new method to fabricate flexible nano-scale membranes using surface micromachining and silica thin films. 

  9. Graphene Harvests Solar Energy To Power ‘Electronic Skin’

    University of Glasgow researchers have developed a layer of graphene that can harvest sunlight to power 'electronic skin,' whose development holds much promise in the fields of prosthetics and robotics.

  10. FDA Officials Make A Case For Re-Authorization Of User Fees Before Senate Committee

    Top officials of the U.S Food and Drug Administration (FDA) testified before a Senate HELP (Health, Education, Labor, Pensions) Committee to stress the rationale for re-authorizing user fee programs designed to streamline regulation and speed access to innovative and lifesaving medical products.